Catalyst Wire Dossier Catalyst Wire Dossier

PREVYMIS

letermovir · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

46 regulatory and trial events tracked for PREVYMIS, covering 2017-11-08 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus [Phase 1]

See pricing